Rheumatology

Back to articles

Temporary stopping MTX improves immunogenicity of influenza vaccination

KEY POINT

In patients with rheumatoid arthritis (RA), holding the methotrexate (MTX) dose for 2 weeks after administration of the seasonal influenza vaccine improved vaccine response compared with patients who continued MTX treatment, according to results of a randomized trial published in BMJ.